Nanoparticles for cardiovascular diseases: identifying and overcoming barriers in translating preclinical success to clinical applications

医学 制药技术 纳米颗粒 医学物理学 重症监护医学 纳米技术 梅德林 计算生物学 临床试验 临床实习 药理学 计算机科学
作者
Ali Ahmadi,Ahmed Refaat,Kaiting Miao,Mark Louis P. Vidallon,James D. McFadyen,Xiaowei Wang,Karlheinz Peter
出处
期刊:Advanced Drug Delivery Reviews [Elsevier BV]
卷期号:239: 115980-115980
标识
DOI:10.1016/j.addr.2026.115980
摘要

Nanoparticles (NPs) have emerged as versatile platforms for drug delivery in cardiovascular diseases (CVDs), demonstrating robust efficacy in preclinical models by stabilizing atherosclerotic plaques, promoting safe and efficient thrombolysis, and mitigating ischemia-reperfusion injury. These advances highlight the maturation of cardiovascular nanomedicine; however, translation to clinical practice remains limited. This gap between laboratory success and clinical adoption reflects broader challenges in nanomedicine design, including suboptimal delivery to diseased tissues, limited efficacy of single therapeutic payload-based strategies in addressing the multifaceted inflammatory pathways driving CVDs, NPs' immunogenicity, and scale-up feasibility. Addressing these barriers is particularly critical in CVDs, where therapeutic success depends on precise engagement with multiple molecular and cellular drivers of disease. This review discusses the evolving landscape of cardiovascular nanomedicine, focusing on four aspects. First, we highlight advances in NPs bioengineering strategies, such as refined targeting moieties, optimized physicochemical properties, and responsiveness to endogenous and external stimuli that enhance organ- and cell-specific delivery in atherosclerosis, myocardial infarction, and stroke. Second, we discuss analytical innovations that improve characterization and control of NPs' biodistribution, enabling more rational targeting. Third, we evaluate therapeutic payloads, emphasizing how RNA-based and immunomodulatory agents represent a meaningful step toward clinical translation. Fourth, we outline approaches to addressing persistent challenges in safety and scalable manufacturing. Together, these developments establish a foundation for translating NP design principles into practical cardiovascular therapies. With continued progress in targeted delivery, clinical safety, and production scalability, cardiovascular nanomedicine is increasingly well-positioned to translate preclinical advances to transformative patient outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
AlbertChung完成签到,获得积分10
1秒前
泡猪脚完成签到 ,获得积分10
1秒前
义气猫咪发布了新的文献求助10
1秒前
专注半鬼发布了新的文献求助10
2秒前
摇摆小狗完成签到,获得积分10
2秒前
YIYI发布了新的文献求助10
2秒前
4秒前
Daisy完成签到,获得积分10
4秒前
orixero的应助被mianyu采纳,获得10
5秒前
6秒前
科研人完成签到,获得积分10
6秒前
Kiki发布了新的文献求助10
6秒前
NM77完成签到,获得积分10
7秒前
漫漫驳回了英姑的应助
7秒前
8秒前
义气猫咪完成签到,获得积分10
8秒前
初景的应助被acffo采纳,获得20
8秒前
粗暴的又蓝完成签到,获得积分10
9秒前
9秒前
9秒前
NM77发布了新的文献求助10
10秒前
sly发布了新的文献求助10
10秒前
大萌发布了新的文献求助10
10秒前
10秒前
11秒前
11秒前
谨慎映冬完成签到,获得积分10
11秒前
chengsi发布了新的文献求助10
11秒前
深情安青的应助被糖布里部采纳,获得10
11秒前
11秒前
12秒前
12秒前
12秒前
12秒前
12秒前
12秒前
12秒前
12秒前
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181949
求助须知:如何正确求助?哪些是违规求助? 9571702
关于积分的说明 21819272
捐赠科研通 7778399
什么是DOI,文献DOI怎么找? 3433572
关于科研通互助平台的介绍 2557769
邀请新用户注册赠送积分活动 2479630